About Virtue Diagnostics
Virtue Diagnostics is a company based in Suzhou (China) founded in 2019. Virtue Diagnostics has raised $130 million across 2 funding rounds from investors including Sequoia Capital, Morningside and Yuanhe Holdings. Virtue Diagnostics has completed 1 acquisition, including Labtest. Virtue Diagnostics operates in a competitive market with competitors including Abingdon Health, Olink, US BioTek Laboratories, Spear Bio and Eclipse Bio, among others.
- Headquarter Suzhou, China
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$130 M (USD)
in 2 rounds
-
Latest Funding Round
$100 M (USD), Series B
Jan 06, 2022
-
Investors
Sequoia Capital
& 3 more
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Virtue Diagnostics
Unlock access to complete
Unlock access to complete
Funding Insights of Virtue Diagnostics
Virtue Diagnostics has successfully raised a total of $130M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $100 million completed in January 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Virtue Diagnostics
Virtue Diagnostics has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include Sequoia Capital, Morningside and Yuanhe Holdings.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multiple sectors are invested in by Morningside, a VC fund.
|
Locked | Locked | Locked | |
|
Venture capital firm focused on early-stage investments
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Virtue Diagnostics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Virtue Diagnostics
Virtue Diagnostics has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Labtest.
Investment portfolio details for Virtue Diagnostics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Scientific consulting, technical assistance, and laboratory services are offered.
|
Locked | Locked | 1971 | Locked |
Complete acquisition details for Virtue Diagnostics
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Virtue Diagnostics
Detailed financials for Virtue Diagnostics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Virtue Diagnostics Comparisons
Peer comparison for Virtue Diagnostics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Virtue Diagnostics
Virtue Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abingdon Health, Olink, US BioTek Laboratories, Spear Bio and Eclipse Bio, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of immunoassays for diagnostic purposes
|
|
| Locked | Locked | Locked |
Provider of products and services for human protein biomarker research and development
|
|
| Locked | Locked | Locked |
Provider of enzyme-linked immunosorbent assay technology services
|
|
| Locked | Locked | Locked |
Developer of ultrasensitive immunoassays and proteomics platforms for detecting protein biomarkers
|
|
| Locked | Locked | Locked |
Cell-free immunoassays are developed to identify RNA binding protein targets.
|
Detailed competitors of Virtue Diagnostics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Virtue Diagnostics
Complete news archive for Virtue Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Virtue Diagnostics
Virtue Diagnostics was founded in 2019 and raised its 1st funding round 1 year after it was founded.
Virtue Diagnostics is headquartered in Suzhou, China. It is registered at Suzhou, Jiangsu, China.
Johnson Zhang is the current CEO of Virtue Diagnostics.
Virtue Diagnostics is a funded company, having raised a total of $130M across 2 funding rounds to date.
Virtue Diagnostics was founded in 2019 in Suzhou, China, within the biotechnology sector. An in vitro assay platform is developed and supplied for diagnostic applications. The technology is applied in early screening, diagnosis, treatment monitoring, and minimal residual disease management. It addresses infectious diseases, cancer, maternal and fetal health, and chronic conditions, supporting healthcare operations across these areas.
Virtue Diagnostics's top competitors include Abingdon Health, Eclipse Bio and Spear Bio.
Virtue Diagnostics has made 1 acquisition, including Labtest.
Virtue Diagnostics has 4 investors. Key investors include Sequoia Capital, Morningside, Yuanhe Holdings, and Lilly Asia Ventures.